Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-26 5:25 pm Purchase |
2023-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
BLACKROCK INC BLK |
3,675,692 6.700% |
450,976 (+13.98%) |
Filing History |
| 2023-11-20 4:15 pm Purchase |
2023-11-10 | 13G | Celldex Therapeutics, Inc. CLDX |
Point72 Asset Management, L.P. | 3,622,136 6.600% |
3,622,136 (New Position) |
Filing History |
| 2023-05-10 08:54 am Purchase |
2023-04-28 | 13G | Celldex Therapeutics, Inc. CLDX |
WELLINGTON MANAGEMENT CO LLP | 4,781,497 10.120% |
133,585 (+2.87%) |
Filing History |
| 2023-02-14 1:18 pm Sale |
2022-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
VIKING GLOBAL INVESTORS LP | 0 0.000% |
-2,366,385 (Position Closed) |
Filing History |
| 2023-02-14 10:08 am Sale |
2022-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
RTW Investments, LP | 3,084,215 6.500% |
-837,364 (-21.35%) |
Filing History |
| 2023-02-09 11:12 am Purchase |
2022-12-30 | 13G | Celldex Therapeutics, Inc. CLDX |
The Vanguard Group | 2,513,564 5.340% |
100,508 (+4.17%) |
Filing History |
| 2023-02-09 09:59 am Purchase |
2023-02-09 | 13G | Celldex Therapeutics, Inc. CLDX |
FMR CORP | 7,064,974 14.999% |
65,394 (+0.93%) |
Filing History |
| 2023-02-06 2:49 pm Purchase |
2022-12-30 | 13G | Celldex Therapeutics, Inc. CLDX |
WELLINGTON MANAGEMENT CO LLP | 4,647,912 9.870% |
4,647,912 (New Position) |
Filing History |
| 2023-02-01 10:22 am Sale |
2022-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
STATE STREET CORP STT |
2,291,454 4.870% |
-76,586 (-3.23%) |
Filing History |
| 2023-01-31 5:52 pm Purchase |
2022-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
BLACKROCK INC BLK |
3,224,716 6.800% |
123,686 (+3.99%) |
Filing History |
| 2022-06-10 4:15 pm Purchase |
2022-05-31 | 13G | Celldex Therapeutics, Inc. CLDX |
VIKING GLOBAL INVESTORS LP | 2,366,385 5.100% |
2,366,385 (New Position) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
Redmile Group LLC | 2,165,586 4.600% |
-546,030 (-20.14%) |
Filing History |
| 2022-02-14 08:41 am Purchase |
2021-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
RTW Investments, LP | 3,921,579 8.400% |
498,724 (+14.57%) |
Filing History |
| 2022-02-10 1:29 pm Purchase |
2021-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
STATE STREET CORP STT |
2,368,040 5.070% |
2,368,040 (New Position) |
Filing History |
| 2022-02-10 09:15 am Sale |
2021-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
ADAGE CAPITAL PARTNERS GP LLC | 650,000 1.390% |
-1,850,000 (-74.00%) |
Filing History |
| 2022-02-09 3:33 pm Purchase |
2021-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
The Vanguard Group | 2,413,056 5.170% |
2,413,056 (New Position) |
Filing History |
| 2022-02-09 09:11 am Purchase |
2022-02-08 | 13G | Celldex Therapeutics, Inc. CLDX |
FMR CORP | 6,999,580 14.999% |
1,384,247 (+24.65%) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
BLACKROCK INC BLK |
3,101,030 6.600% |
3,101,030 (New Position) |
Filing History |
| 2022-01-18 4:28 pm Unchanged |
2021-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
Cowen Financial Products LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-01-14 1:29 pm Sale |
2021-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
Cowen Financial Products LLC | 0 0.000% |
-2,015,513 (Position Closed) |
Filing History |